PB2084: FIRST-LINE TREATMENT IN ADVANCED STAGE FOLICULAR LYMPHOMA: A SINGLE-CENTER EXPERIENCE WITH R-CHOP VS BENDAMUSTINE-RITUXIMAB.
Main Authors: | O. Mompel, C. Amorós, P. López-Menargues, C. Játiva, A. Cámara, R. García-Serra, M. J. Lis, M. T. Orero, S. Ortiz, M. Linares |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000851168.63343.97 |
Similar Items
-
PB2070: EFFICACY OF RITUXIMAB MAINTENANCE THERAPY IN ADVANCED-STAGE FOLLICULAR LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.
by: C. Amorós, et al.
Published: (2022-06-01) -
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
by: Giulia Bega, et al.
Published: (2021-12-01) -
PB1911: CYTOGENOMIC INTEGRATIVE ANALYSIS OF CLL/SLL PATIENTS AT DISEASE PROGRESSION.
by: Rocío García-Serra, et al.
Published: (2023-08-01) -
2084
by: Jane Otado, et al.
Published: (2017-09-01) -
Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study
by: Yuki Shimizu, et al.
Published: (2023-06-01)